Relevant bibliographies by topics / Severe acute respiratory syndrome (SARS) media

Academic literature on the topic 'Severe acute respiratory syndrome (SARS) media'

Author: Grafiati
Published: 4 June 2021
Last updated: 11 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Severe acute respiratory syndrome (SARS) media.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Severe acute respiratory syndrome (SARS) media"

1

Tice, Alan Douglas, Mitsumasa Kishimoto, Chuong Hoang Dinh, Geoffrey Tak-Kin Lam, and Michelle Marineau. "Knowledge of Severe Acute Respiratory Syndrome among Community Physicians, Nurses, and Emergency Medical Responders." Prehospital and Disaster Medicine 21, no. 3 (June 2006): 183–89. http://dx.doi.org/10.1017/s1049023x00003654.

Full text
Abstract:
AbstractIntroduction:The preparedness levels of front-line clinicians including physicians, nurses, emergency medical responders (EMRs), and other medical staff working in clinics, offices and ambulatory care centers must be assessed, so these personnel are able to deal with communicable and potentially lethal diseases, such as severe acute respiratory syndrome (SARS). In order to determine the knowledge of these clinicians, a survey of their understanding of SARS and their use of educational resources was administered.Methods:A questionnaire was distributed to physicians, nurses, and EMRs attending conferences on SARS in the summer of 2003. Questions related to information sources, knowledge of SARS, and plans implemented in their workplace to deal with it. Statistical analysis was performed using the Statistical Package for the Social Sciences (10.1 Program, SPSS Inc., Chicago, Illinois).Results:A total of 201 community healthcare providers (HCPs) participated in the study. A total of 51% of the participants correctly identified the incubation period of SARS; 48% correctly identified the symptoms of SARS; and 60% knew the recommended infection control precautions to take for families. There was little difference in knowledge among the physicians, nurses, and EMRs evaluated. Media outlets such as newspapers, journals, television, and radio were reported as the main sources of information on SARS. However, there appears to be a growing use of the Internet, which correlated best with the correct answers on symptoms of SARS. Fewer than one-third of respondents were aware of a protocol for SARS in their workplace. A total of 60% reported that N-95 masks were available in their workplace.Conclusion:These findings suggest the need for more effective means of education and training for front-line clinicians, as well as the institution of policies and procedures in medical offices, clinics, and emergency services in the community.
APA, Harvard, Vancouver, ISO, and other styles
2

Muzzatti, Stephen L. "Bits of Falling Sky and Global Pandemics: Moral Panic and Severe Acute Respiratory Syndrome (SARS)." Illness, Crisis & Loss 13, no. 2 (April 2005): 117–28. http://dx.doi.org/10.1177/105413730501300203.

Full text
Abstract:
Whether it's a story about crime, the weather, politics, Hollywood celebrities, or public health, sensationalistic and exploitative coverage is a media staple. The mass media's coverage of the outbreak of Severe Acute Respiratory Syndrome (SARS) in the spring of 2003 was no exception. The media's construction of the source, virulence, and transmissibility of this disease, a previously unknown cousin of the common cold, diverged considerably from its medical realities and contributed to a widespread though short-lived moral panic. Drawing on work in the areas of the sociology of health and critical criminology, this article explores the claims-making activities behind the SARS “epidemic.” Specifically, it addresses how threats to the public well-being are manufactured by the media and how these threats draw upon past and present cultural myths of dangerous “others” and contribute to unwarranted public fear, intolerance, and distrust.
APA, Harvard, Vancouver, ISO, and other styles
3

Bullard, Jared, Kerry Dust, Duane Funk, James E. Strong, David Alexander, Lauren Garnett, Carl Boodman, et al. "Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples." Clinical Infectious Diseases 71, no. 10 (May 22, 2020): 2663–66. http://dx.doi.org/10.1093/cid/ciaa638.

Full text
Abstract:
Abstract Background Reverse-transcription polymerase chain reaction (RT-PCR) has become the primary method to diagnose viral diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). RT-PCR detects RNA, not infectious virus; thus, its ability to determine duration of infectivity of patients is limited. Infectivity is a critical determinant in informing public health guidelines/interventions. Our goal was to determine the relationship between E gene SARS-CoV-2 RT-PCR cycle threshold (Ct) values from respiratory samples, symptom onset to test (STT), and infectivity in cell culture. Methods In this retrospective cross-sectional study, we took SARS-CoV-2 RT-PCR–confirmed positive samples and determined their ability to infect Vero cell lines. Results Ninety RT-PCR SARS-CoV-2–positive samples were incubated on Vero cells. Twenty-six samples (28.9%) demonstrated viral growth. Median tissue culture infectious dose/mL was 1780 (interquartile range, 282–8511). There was no growth in samples with a Ct > 24 or STT > 8 days. Multivariate logistic regression using positive viral culture as a binary predictor variable, STT, and Ct demonstrated an odds ratio (OR) for positive viral culture of 0.64 (95% confidence interval [CI], .49–.84; P < .001) for every 1-unit increase in Ct. Area under the receiver operating characteristic curve for Ct vs positive culture was OR, 0.91 (95% CI, .85–.97; P < .001), with 97% specificity obtained at a Ct of > 24. Conclusions SARS-CoV-2 Vero cell infectivity was only observed for RT-PCR Ct < 24 and STT < 8 days. Infectivity of patients with Ct > 24 and duration of symptoms > 8 days may be low. This information can inform public health policy and guide clinical, infection control, and occupational health decisions. Further studies of larger size are needed.
APA, Harvard, Vancouver, ISO, and other styles
4

Pablo Goldschmidt. "Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) detection pitfalls." International Journal of Science and Research Archive 2, no. 2 (May 30, 2021): 008–17. http://dx.doi.org/10.30574/ijsra.2021.2.2.0049.

Full text
Abstract:
The Severe Acute Respiratory Syndrome (CoVID 19) provoked by Coronavirus 2 (SARS CoV 2) require science-based responses. The aim of this work is to assess pitfalls found during the search of viral genomes due to sampling timing, swabbing, storage, heat-infectivity inactivation and further sample processing. According to several meta-analysis, on the day of symptom onset, the median false-negative rate is estimated to be 38% and decreased to 20% on day 8 (3 days after symptom onset) then increased to 66% on day 21 suggesting that rRT-PCRs adds little information immediately after exposure. RNA isolation from samples requires cautious handling using RNase-free solutions, pipet tips and glassware. The rRT PCR detection limits are estimated between 39 and 779 copies/mL but 3000 to 20.000 copies/ml for the antigen test. External cross contamination by imperceptible splatting requires risk management integrating the Pharmacopoeias by processing at least 10 negative contiguous to 10 positive controls in each sennries of 100 tests. . For Ct >34 it was suggested no transmissible disease. The detection of antibodies one month or later after clinical signs may confirm positivity. Lack of immune response in non-immune compromised asymptomatic people may invalidate positivity. False positive disrupts efficiency for containing infections and leads to societal anxiety undermining health workforce. Because spurious methods create confusion, each step of diagnosis requires quality-control and risk assessment, knowing that rRT PCRs amplify more than 10.000 million times the signal of 1 viral element
APA, Harvard, Vancouver, ISO, and other styles
5

Fwoloshi, Sombo, Jonas Z. Hines, Danielle T. Barradas, Samuel Yingst, Mpanji Siwingwa, Lameck Chirwa, James E. Zulu, et al. "Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers—Zambia, July 2020." Clinical Infectious Diseases 73, no. 6 (March 30, 2021): e1321-e1328. http://dx.doi.org/10.1093/cid/ciab273.

Full text
Abstract:
Abstract Background Healthcare workers (HCWs) in Zambia have become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). However, SARS-CoV-2 prevalence among HCWs is not known in Zambia. Methods We conducted a cross-sectional SARS-CoV-2 prevalence survey among Zambian HCWs in 20 health facilities in 6 districts in July 2020. Participants were tested for SARS-CoV-2 infection using polymerase chain reaction (PCR) and for SARS-CoV-2 antibodies using enzyme-linked immunosorbent assay (ELISA). Prevalence estimates and 95% confidence intervals (CIs), adjusted for health facility clustering, were calculated for each test separately, and a combined measure for those who had PCR and ELISA was performed. Results In total, 660 HCWs participated in the study, with 450 (68.2%) providing a nasopharyngeal swab for PCR and 575 (87.1%) providing a blood specimen for ELISA. Sixty-six percent of participants were females, and median age was 31.5 years (interquartile range, 26.2–39.8). The overall prevalence of the combined measure was 9.3% (95% CI, 3.8%–14.7%). PCR-positive prevalence of SARS-CoV-2 was 6.6% (95% CI, 2.0%–11.1%), and ELISA-positive prevalence was 2.2% (95% CI, .5%–3.9%). Conclusions SARS-CoV-2 prevalence among HCWs was similar to a population-based estimate (10.6%) during a period of community transmission in Zambia. Public health measures such as establishing COVID-19 treatment centers before the first cases, screening for COVID-19 symptoms among patients who access health facilities, infection prevention and control trainings, and targeted distribution of personal protective equipment based on exposure risk might have prevented increased SARS-CoV-2 transmission among Zambian HCWs.
APA, Harvard, Vancouver, ISO, and other styles
6

Pan, Yanfeng, Xue Yu, Xinwei Du, Qingqing Li, Xianyang Li, Tao Qin, Miaomiao Wang, et al. "Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers." Journal of Infectious Diseases 221, no. 12 (April 22, 2020): 1940–47. http://dx.doi.org/10.1093/infdis/jiaa205.

Full text
Abstract:
Abstract Background We retrospectively analyzed 26 persistently asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carriers. Methods Epidemiological and clinical characteristics from the 26 asymptomatic patients with positive results for SARS-CoV-2 ribonucleic acid testing were obtained. Results Twenty-two patients (84.6%) correlated with clustering occurrence. The median period from contact to diagnosis and the last positive nucleic acid test was 19 (8–24 days) and 21.5 days (10–36 days), respectively. The median period from diagnosis to negative nucleic acid test was significantly different between patients with normal or atypical chest computed tomography (CT) findings (n = 16, 61.5%; 7.5 days [2–20 days]) and patients with typical ground-glass or patchy opacities on CT (n = 10, 38.5%; 12.5 days [8–22 days]; P < .01). Seven patients (70.0%) with initial positive nucleic acid test results had a negative result simultaneously with improved CT findings. Obvious improvement in CT findings was observed in 3 patients (30.0%) despite positive nucleic acid test results. Conclusions In asymptomatic patients, changes in biochemical and inflammatory variables are small and changes on chest CT can occur. It is worth noting that the long existence of SARS-CoV-2 in some asymptomatic patients and false-negative results need to be considered in SARS-CoV-2 nucleic acid test.
APA, Harvard, Vancouver, ISO, and other styles
7

Lewison, Grant. "The reporting of the risks from severe acute respiratory syndrome (SARS) in the news media, 2003–2004." Health, Risk & Society 10, no. 3 (June 2008): 241–62. http://dx.doi.org/10.1080/13698570802160962.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Keshavarz, Behnam, Joesph R. Wiencek, Lisa J. Workman, Matthew D. Straesser, Lyndsey M. Muehling, Glenda Canderan, Fabrizio Drago, et al. "Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP." International Archives of Allergy and Immunology 182, no. 5 (2021): 417–24. http://dx.doi.org/10.1159/000514203.

Full text
Abstract:
<b><i>Background:</i></b> Detailed understanding of the immune response to severe acute respiratory syndrome coronavirus (SARS-CoV)-2, the cause of coronavirus disease 2019 (CO­VID-19) has been hampered by a lack of quantitative antibody assays. <b><i>Objective:</i></b> The objective was to develop a quantitative assay for IgG to SARS-CoV-2 proteins that could be implemented in clinical and research laboratories. <b><i>Methods:</i></b> The biotin-streptavidin technique was used to conjugate SARS-CoV-2 spike receptor-binding domain (RBD) or nucleocapsid protein to the solid phase of the ImmunoCAP. Plasma and serum samples from patients hospitalized with COVID-19 (<i>n</i> = 60) and samples from donors banked before the emergence of COVID-19 (<i>n</i> = 109) were used in the assay. SARS-CoV-2 IgG levels were followed longitudinally in a subset of samples and were related to total IgG and IgG to reference antigens using an ImmunoCAP 250 platform. <b><i>Results:</i></b> At a cutoff of 2.5 μg/mL, the assay demonstrated sensitivity and specificity exceeding 95% for IgG to both SARS-CoV-2 proteins. Among 36 patients evaluated in a post-hospital follow-up clinic, median levels of IgG to spike-RBD and nucleocapsid were 34.7 μg/mL (IQR 18–52) and 24.5 μg/mL (IQR 9–59), respectively. Among 17 patients with longitudinal samples, there was a wide variation in the magnitude of IgG responses, but generally the response to spike-RBD and to nucleocapsid occurred in parallel, with peak levels approaching 100 μg/mL, or 1% of total IgG. <b><i>Conclusions:</i></b> We have described a quantitative assay to measure IgG to SARS-CoV-2 that could be used in clinical and research laboratories and implemented at scale. The assay can easily be adapted to measure IgG to mutated COVID-19 proteins, has good performance characteristics, and has a readout in standardized units.
APA, Harvard, Vancouver, ISO, and other styles
9

Shen, Zijie, Yan Xiao, Lu Kang, Wentai Ma, Leisheng Shi, Li Zhang, Zhuo Zhou, et al. "Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients With Coronavirus Disease 2019." Clinical Infectious Diseases 71, no. 15 (March 9, 2020): 713–20. http://dx.doi.org/10.1093/cid/ciaa203.

Full text
Abstract:
Abstract Background A novel coronavirus (CoV), severe acute respiratory syndrome (SARS)–CoV-2, has infected &gt;75 000 individuals and spread to &gt;20 countries. It is still unclear how fast the virus evolved and how it interacts with other microorganisms in the lung. Methods We have conducted metatranscriptome sequencing for bronchoalveolar lavage fluid samples from 8 patients with SARS–CoV-2, and also analyzed data from 25 patients with community-acquired pneumonia (CAP), and 20 healthy controls for comparison. Results The median number of intrahost variants was 1–4 in SARS–CoV-2–infected patients, ranged from 0 to 51 in different samples. The distribution of variants on genes was similar to those observed in the population data. However, very few intrahost variants were observed in the population as polymorphisms, implying either a bottleneck or purifying selection involved in the transmission of the virus, or a consequence of the limited diversity represented in the current polymorphism data. Although current evidence did not support the transmission of intrahost variants in a possible person-to-person spread, the risk should not be overlooked. Microbiotas in SARS–CoV-2–infected patients were similar to those in CAP, either dominated by the pathogens or with elevated levels of oral and upper respiratory commensal bacteria. Conclusion SARS–CoV-2 evolves in vivo after infection, which may affect its virulence, infectivity, and transmissibility. Although how the intrahost variant spreads in the population is still elusive, it is necessary to strengthen the surveillance of the viral evolution in the population and associated clinical changes.
APA, Harvard, Vancouver, ISO, and other styles
10

Rabi, Firas A., Mazhar S. Al Zoubi, Ghena A. Kasasbeh, Dunia M. Salameh, and Amjad D. Al-Nasser. "SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far." Pathogens 9, no. 3 (March 20, 2020): 231. http://dx.doi.org/10.3390/pathogens9030231.

Full text
Abstract:
In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Severe acute respiratory syndrome (SARS) media"

1

au, johnbott@westnet com, and John Arthur Bottomley. "A mediated crisis : news and the national mind." Murdoch University, 2008. http://wwwlib.murdoch.edu.au/adt/browse/view/adt-MU20081113.143044.

Full text
Abstract:
The thesis examines a mediated crisis and how The Straits Times and The Australian approach the reporting of Severe Acute Respiratory Syndrome (SARS). It looks at how this mediated crisis exemplifies the culture of the national newspaper and in turn how the national newspaper has an historical influence on the national psyche. A total of 649 reports and headlines and 141 letters about SARS in The Straits Times (including The Straits Time Interactive) were examined from April 2003 to November 2003 as were 125 headlines from The Australian. The early sections of the thesis discuss how a crisis makes news; examine how the media report a crisis and what emphasis is given to aspects such as: actors, primary definers, vocabulary, lexical choices, subjects, themes, issues and value dimension or stance. The first chapter defines crisis, journalism and crisis journalism and discusses where the latter sits within the continuing expansion and development of major theoretical frameworks, including living in a risk society. The implication here is that crisis and risk have a symbiotic relationship. Historical perspectives of news are discussed in Chapter 2, and the newspaper is placed within the context of contemporary media. The chapter discusses how newspapers are aligned with the concept of the national mind and demonstrates the roles and formations of the two newspapers in relation to the SARS crisis. Chapter 3 codes the headlines, article titles and subtitles of The Straits Times and The Australian and using content analysis of the headlines, analyses the reporting of a serious health crisis SARS that lasted from March to November, 2003. The quantification within content analysis enables a researcher to read and interpret questions that relate to the intensity of meaning in texts, their social impact, the relationships between media texts and the realities and representations they reflect (Hansen et al, 1998). The theory and method of content analysis is used in this chapter to consider differences between The Straits Times and The Australian and to exemplify the media’s representation of the narratives of SARS as it happened in the countries of Singapore and Australia. Aspects of crisis and risk, the newspaper and the national mind, narratives, presentations, and post SARS events are discussed in the last chapter. It is concluded from these discussions there is a world narrative that tells the story of how the human condition likes to live and rely on a safe social environment always being available. The relationship between a mediated crisis and risk are also discussed. In addition, it is maintained that reporting in 2003 was not just about SARS but a way of reporting that allowed one to view journalism as an aid to good governance, particularly with regard to living in a risk and crisis-ridden society.
APA, Harvard, Vancouver, ISO, and other styles
2

Chu, Chung-ming. "Clinical aspects of severe acute respiratory syndrome (SARS)." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31937925.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chu, Chung-ming, and 朱頌明. "Clinical aspects of severe acute respiratory syndrome (SARS)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B31937925.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lau, Yik-Chung. "Numerical simulation of severe acute respiratory syndrome (SARS) epidemics /." View abstract or full-text, 2004. http://library.ust.hk/cgi/db/thesis.pl?PHYS%202004%20LAU.

Full text
Abstract:
Thesis (M. Phil.)--Hong Kong University of Science and Technology, 2004.
Includes bibliographical references (leaves 43-44). Also available in electronic version. Access restricted to campus users.
APA, Harvard, Vancouver, ISO, and other styles
5

Chauhan, Vinita Singh. "Molecular characterization of severe acute respiratory syndrome (SARS) coronavirus - nucleocapsid protein." Diss., Manhattan, Kan. : Kansas State University, 2006. http://hdl.handle.net/2097/152.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ching, Chi-yun Johannes. "Study of host genetic susceptibility to severe acute respiratory syndrome (SARS) infection." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B40687648.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ching, Chi-yun Johannes, and 程子忻. "Study of host genetic susceptibility to severe acute respiratory syndrome (SARS) infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40687648.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chow, Yan-ching Ken, and 周恩正. "Characterization of the apoptotic properties of severe acute respiratory syndrome coronavirus (SARS-CoV) structural proteins." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B30105493.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Law, Ka-man. "Vaccine development against the severe acute respiratory syndrome-coronavirus (SARS-CoV) using SARS-CoV spike protein." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B36774480.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Law, Ka-man, and 羅嘉敏. "Vaccine development against the severe acute respiratory syndrome-coronavirus (SARS-CoV) using SARS-CoV spike protein." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B36774480.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Severe acute respiratory syndrome (SARS) media"

1

Okeyo, T. M. Family education handbook on SARS, Severe Acute Respiratory Syndrome. Nairobi: Centre for Quality in Healthcare Organization, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sujudi, Achmad. Menangkal badai: Pengalaman mencegah ancaman severe acute respiratory syndrome (SARS) tahun 2003. Jakarta: Departemen Kesehatan R.I., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Serradell, Joaquima. SARS. Edited by Babcock Hilary. 2nd ed. New York: Chelsea House, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Serradell, Joaquima. SARS. 2nd ed. New York: Chelsea House, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Serradell, Joaquima. SARS. Edited by Babcock Hilary. 2nd ed. New York: Chelsea House, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hilary, Babcock, ed. SARS. 2nd ed. New York: Chelsea House, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Severe acute respiratory syndrome (SARS): Hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session on examining the status of the severe acute respiratory syndrome threat, April 29, 2003. Washington: U.S. G.P.O., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Severe acute respiratory syndrome threat (SARS): Hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session on examining the severe acute respiratory syndrome threat, focusing on the issues of vaccine development, drug screening, and clinical research, April 7, 2003. Washington: U.S. G.P.O., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ahuja, Anil T. Imaging in SARS. London: GMM, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Twenty-first century plague: The story of SARS. Baltimore, Md: John Hopkins University Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Severe acute respiratory syndrome (SARS) media"

1

Leung, CW. "SARS in Children." In Severe Acute Respiratory Syndrome, 30–35. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ooi, Clara GC. "Radiology of SARS." In Severe Acute Respiratory Syndrome, 42–49. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Peiris, Malik, and Albert DME Osterhaus. "Aetiology of SARS." In Severe Acute Respiratory Syndrome, 50–57. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Heymann, David L. "SARS: A Global Perspective." In Severe Acute Respiratory Syndrome, 13–20. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hayden, Frederick G., and Mark R. Denison. "Antiviral Agents for SARS." In Severe Acute Respiratory Syndrome, 184–202. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Drosten, C., KH Chan, and LLM Poon. "Viral Diagnosis of SARS." In Severe Acute Respiratory Syndrome, 64–71. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Guan, Yi, Hume Field, Gavin JD Smith, and Honglin Chen. "SARS Coronavirus: An Animal Reservoir?" In Severe Acute Respiratory Syndrome, 79–83. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Merianos, Angela, Robert Condon, Hitoshi Oshitani, Denise Werker, and Roberta Andraghetti. "Epidemiology and Transmission of SARS." In Severe Acute Respiratory Syndrome, 100–110. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Peiris, J. S. M., Y. Guan, L. L. M. Poon, V. C. C. Cheng, J. M. Nicholls, and K. Y. Yuen. "Severe Acute Respiratory Syndrome (SARS)." In Emerging Infections 7, 23–50. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555815585.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kamieński, Łukasz. "Severe Acute Respiratory Syndrome (SARS)." In The Palgrave Encyclopedia of Global Security Studies, 1–8. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-74336-3_555-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Severe acute respiratory syndrome (SARS) media"

1

Huang, Yuxia. "Modeling the severe acute respiratory syndrome (SARS) outbreak in Beijing." In the 1st International Conference and Exhibition. New York, New York, USA: ACM Press, 2010. http://dx.doi.org/10.1145/1823854.1823895.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

BURIOT, DIEGO. "HEALTH AND SECURITY SEVERE ACUTE RESPIRATORY SYNDROME (SARS): TAKING A NEW THREAT SERIOUSLY." In Fourth Centenary of the Foundation of the First Academy of Sciences: “Academia Lynceorum” by Federico Cesi and Pope Clemente VIII. WORLD SCIENTIFIC, 2004. http://dx.doi.org/10.1142/9789812702753_0023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Redondo Galán, C., M. Ferris Villanueva, D. González Vaquero, MD Rivas Rodríguez, and JF Rangel Mayoral. "5PSQ-172 Experience with tocilizumab in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.291.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lazarus, Theophilus. "SARS-CoV-2 infection and neuropsychological outcomes." In 2nd International Neuropsychological Summer School named after A. R. Luria “The World After the Pandemic: Challenges and Prospects for Neuroscience”. Ural University Press, 2020. http://dx.doi.org/10.15826/b978-5-7996-3073-7.10.

Full text
Abstract:
The entire world is currently confronted with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS.CoV.2), a novel betacoronavirus causing the deadly pandemic of coronavirus disease 2019 (COVID.19). Since there is now increasing reports of neurological and cognitive problems, the impact of COVID.19 on neuropsychological functioning is unknown but is likely to leave residual problems.
APA, Harvard, Vancouver, ISO, and other styles
5

Legband, Nathan, Jameel Feshitan, Mark Borden, and Benjamin Terry. "Living Without Breathing: A Study in Extrapulmonary Respiration Using a Novel Oxygen Carrier." In ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14735.

Full text
Abstract:
Pulmonary failure results when the lungs experience significant damage and are unable to supply the body and brain with oxygen. Pulmonary failure has many causes including lung cancer, physical trauma, acute respiratory distress syndrome (ARDS), aerosolized bioterrorism agents and diseases such as severe acute respiratory syndrome (SARS), pneumonia, and tuberculosis [1,2].
APA, Harvard, Vancouver, ISO, and other styles
6

Bayram, H., Kayalar, A. Ari, G. Babuçcu, N. Konyalilar, Do&#287;an, F. Can, et al. "Presence of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) RNA on Particulate Matters: A Multi Central Study in Turkey." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Haddadi, S., L. Escudero Méndez, M. Batra, T. Runxia, C. Zhang, C. Emile, C. Sacher, et al. "Role of Immunoglobulin G (IgG) Against N-protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) in Coronavirus Disease 2019 (COVID19) Clinical Outcomes." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2822.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ramona, Stoicescu, Stoicescu Razvan-Alexandru, Codrin Gheorghe, and Schroder Verginica. "LABORATORY METHODS AND PREVALENCE OF SARS-COV-2 INFECTIONS IN THE 2ND SEMESTER OF 2021 IN THE EMERGENCY CLINICAL COUNTY HOSPITAL OF CONSTANTA." In GEOLINKS Conference Proceedings. Saima Consult Ltd, 2021. http://dx.doi.org/10.32008/geolinks2021/b1/v3/11.

Full text
Abstract:
"Diagnosing infections with SARS-CoV-2 is still of great interest due to the health and economic impact of COVID pandemic. The 4th wave of the COVID-19 pandemic is expected and is considered to be stronger and faster due to the dominance of Delta variant which is highly contagious [1]. SARS-CoV-2 also known as 2019-nCoV is one of the three coronaviruses (together with SARS-CoV or SARS-CoV1/Severe acute respiratory syndrome coronavirus), MERS-CoV /Middle East Respiratory Syndrome coronavirus) which can cause severe respiratory tract infections in humans [2]. Early diagnosis in COVID 19 infection is the key for preventing infection transmission in collectivity and proper medical care for the ill patients. Gold standard for diagnosing SARS-Co-V-2 infection according to WHO recommendation is using nucleic acid amplification tests (NAAT)/ reverse transcription polymerase chain reaction (RT-PCR). The search is on to develop reliable but less expensive and faster diagnostic tests that detect antigens specific for SARS-CoV-2 infection. Antigen-detection diagnostic tests are designed to directly detect SARSCoV-2 proteins produced by replicating virus in respiratory secretions so-called rapid diagnostic tests, or RDTs. The diagnostic development landscape is dynamic, with nearly a hundred companies developing or manufacturing rapid tests for SARS-CoV-2 antigen detection [3]. In the last 3 months our hospital introduced the antigen test or Rapid diagnostic tests (RDT) which detects the presence of viral proteins (antigens) expressed by the COVID-19 virus in a sample from the respiratory tract of a person. All RDT were confirmed next day with a RT-PCR. The number of positive cases detected during 3 months in our laboratory was 425. There were 326 positive tests in April, 106 positive tests in May and 7 positive tests in June. Compared with the number of positive tests in the 1st semester of 2021, the positive tests have significantly declined."
APA, Harvard, Vancouver, ISO, and other styles
9

Obreshkov, Ivan. "THE SARS-CoV-2 PANDEMIC IN BULGARIA AND THE CHALLENGES OF REAL-TIME DISTANCE LEARNING FOR TOURISM UNIVERSITY STUDENTS." In TOURISM AND CONNECTIVITY 2020. University publishing house "Science and Economics", University of Economics - Varna, 2020. http://dx.doi.org/10.36997/tc2020.51.

Full text
Abstract:
The severe acute respiratory syndrome coronavirus SARS-CoV-2 pandemic brought changes in various aspects of life, including educational field. The present study reveals some of the challenges related to real-time distance learning for university students majoring in tourism in Plovdiv, Bulgaria. The study includes Bulgarian and international students in full-time and part-time bachelor's and master's tourism programs, in which real-time distance education was introduced for the first time. The current study could be a starting point for improving the organization and quality of education of Tourism students, as well as for faster overcoming of related difficulties in communication with students.
APA, Harvard, Vancouver, ISO, and other styles
10

"A Time-Series Intervention Analysis of the Effects of Major Political Incidents, Financial Crises, and Health Hazards (Severe Acute Respiratory Syndrome [SARS]) on Property Prices: A Hong Kong Case Study." In 2005 European Real Estate Society conference in association with the International Real Estate Society: ERES Conference 2005. ERES, 2005. http://dx.doi.org/10.15396/eres2005_244.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Severe acute respiratory syndrome (SARS) media"

1

Fuller, Julie, Keith Hanley, Robert Schultz, Michael Lewis, Nicole Freed, Michael Ellis, Viseth Ngauy, Richard Stoebner, Margaret Ryan, and Kevin Russel. Surveillance for Respiratory Infections, Including Severe Acute Respiratory, Syndrome (SARS), in Cobra Gold 2003. Fort Belvoir, VA: Defense Technical Information Center, May 2004. http://dx.doi.org/10.21236/ada455915.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Severe acute respiratory syndrome (SARS) media' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography